Kwang Dong Pharmaceutical Co., Ltd. (KRX: 009290)

Kwang Dong Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	215,233	297,799	244,840	305,229	421,076	263,211
Market Cap Growth	-5.09%	21.63%	-19.78%	-27.51%	59.98%	-5.31%
Enterprise Value	375,811	283,794	196,173	300,829	390,078	300,684
Last Close Price	5370.00	7430.00	5879.78	7209.84	9813.83	6303.29
PE Ratio	6.35	8.14	10.00	12.34	8.77	10.84
Forward PE	-	14.32	14.32	14.32	14.32	14.32
PS Ratio	0.13	0.20	0.17	0.23	0.34	0.21
PB Ratio	0.38	0.51	0.45	0.58	0.84	0.59
P/TBV Ratio	0.49	0.59	0.49	0.63	0.90	0.65
P/FCF Ratio	-	-	6.54	9.80	23.97	15.81
P/OCF Ratio	-	-	3.90	5.56	18.45	8.99
EV/Sales Ratio	0.23	0.19	0.14	0.22	0.31	0.24
EV/EBITDA Ratio	7.49	5.16	3.75	5.09	5.88	4.96
EV/EBIT Ratio	10.33	6.75	5.13	6.69	8.37	7.19
EV/FCF Ratio	-3.57	-	5.24	9.66	22.21	18.06
Debt / Equity Ratio	0.46	0.40	0.25	0.25	0.22	0.25
Debt / EBITDA Ratio	5.54	4.29	2.64	2.24	1.65	1.85
Debt / FCF Ratio	-	-	3.69	4.24	6.25	6.74
Asset Turnover	1.51	1.51	1.58	1.56	1.53	1.62
Inventory Turnover	6.75	6.95	7.34	6.58	6.21	7.51
Quick Ratio	0.92	1.03	1.23	1.32	1.24	1.13
Current Ratio	1.38	1.46	1.71	1.81	1.93	1.63
Return on Equity (ROE)	6.07%	6.94%	4.97%	4.96%	9.60%	5.16%
Return on Assets (ROA)	2.14%	2.62%	2.63%	3.28%	3.59%	3.43%
Return on Capital (ROIC)	2.78%	3.49%	3.56%	4.42%	4.97%	4.78%
Earnings Yield	15.74%	12.41%	9.87%	7.87%	10.77%	8.76%
FCF Yield	-48.90%	-15.62%	15.29%	10.20%	4.17%	6.32%
Dividend Yield	1.89%	1.35%	1.70%	1.39%	1.02%	1.27%
Payout Ratio	11.83%	11.11%	16.99%	17.10%	6.98%	13.94%
Buyback Yield / Dilution	2.19%	1.48%	0.11%	-1.48%	-2.24%	2.29%
Total Shareholder Return	4.08%	2.83%	1.82%	-0.09%	-1.22%	3.56%

Source: S&P Capital IQ. Standard template. Financial Sources.